Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PAR Active Technologies was a specialized biotechnology company focused on the development of its proprietary Pressure-Activated Release (PAR) drug delivery platform. Based in Research Triangle Park, North Carolina, the company's technology was designed to provide controlled and sustained release of active pharmaceutical ingredients (APIs) through a mechanical, pressure-sensitive mechanism. This platform was particularly suited for topical, transdermal, and mucosal delivery, aiming to improve the therapeutic window and patient compliance for various medications. The company operated primarily as a technology partner, collaborating with pharmaceutical and consumer health companies to integrate its unique delivery system into their products. By leveraging mechanical release rather than traditional chemical degradation, the PAR system offered a distinct method for managing drug delivery profiles. Although the company focused on high-value applications in dermatology and pain management, it was officially dissolved in late 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Par Active Technologies.